期刊文献+

肝细胞癌中SETDB1的表达及其对肿瘤生长的影响 被引量:3

Expression of SETDB1 in hepatocellular carcinoma and its role for tumor growth
在线阅读 下载PDF
导出
摘要 目的探讨人肝细胞癌(HCC)中组蛋白赖氨酸N端甲基转移酶SET结构域分支型1(SETDB1)的表达及其对肿瘤生长的影响。方法采用免疫组织化学法检测HCC组织中SETDB1的表达水平;shRNA慢病毒转染MHCC97H细胞构建SETDB1稳定敲低细胞系;平板克隆形成试验及流式细胞仪检测细胞增殖、凋亡的变化;裸鼠皮下移植瘤模型检测沉默SETDB1对肿瘤生长的影响;Western blot检测组蛋白H3K9me3表达变化。结果在HCC组织中SETDB1表达水平与正常肝组织比较有差异(P<0.05);SETDB1高表达患者肿瘤体积更大(P<0.05);下调SETDB1能抑制MHCC97H细胞增殖,促进细胞凋亡(P<0.05);下调SETDB1的表达也抑制MHCC97H细胞裸鼠皮下移植瘤的生长(P<0.05);沉默SETDB1后MHCC97H细胞内H3K9me3的表达降低(P <0.05),p53表达升高(P <0.05)。结论 SETDB1在HCC中表达升高,下调SETDB1能够通过组蛋白H3在K9位点的甲基化而发挥抗肿瘤生长作用。 Objective To investigate the expression of SETDB1 in hepatocellular carcinoma(HCC)and its role in tumor growth.Methods The expression of SETDB1 in HCC was detected by immunohistochemical staining.SETDB1 specific shRNA-lentivirus was used to knock down the expression of SETDB1 in MHCC97H cells.Clone formation assay and flow cytometry were used to detect cell proliferation and apoptosis.A subcutaneous xenotransplanted tumor model was used to measure the effect of SETDB1 on tumor growth in vivo.Western blot was used to detect the expression of H3K9me3.Results The expression of SETDB1 in the HCC tissues was higher than that in the normal liver tissues(P<0.05).The tumor volume was bigger in the patients with high SETDB1 expression(P<0.05).Down-regulation of SETDB1 suppressed proliferation and enhanced apoptosis in MHCC97H cells(P<0.05).Knockdown of SETDB1 still inhibited in vivo tumor growth in nude mice(P<0.05).Moreover,the expression of H3K9me3 in MHCC97H cells was impaired due to the depletion of SETDB1(P<0.05),but the p53 expression was up-regulated(P<0.05).Conclusions The expression of SETDB1 increases in HCC tissues.Downregulation of SETDB1 could inhibit HCC growth in vitro and in vivo through inhibiting H3K9 trimethylation.
作者 陈静 刘莉 郑思琳 Jing Chen;Li Liu;Si-lin Zheng(Department of Hepatobiliary Surgery,the Affiliated Hospital of Southwest Medical University,Luzhou,Sichuan 646099,China)
出处 《中国现代医学杂志》 CAS 2018年第32期38-43,共6页 China Journal of Modern Medicine
关键词 SETDB1 肝细胞癌 表达 生长 H3K9me3 SETDB1 hepatocellular carcinoma expression growth H3K9me3
作者简介 [通信作者]郑思琳,E-mail:791697074@qq.com。
  • 相关文献

参考文献3

二级参考文献44

  • 1Siegel R, Naishadham D, Jemal A. Cancer statistics for Hispanics/Latinos, 2012. CA Cancer J Clin 2012,62: 283-98.
  • 2Roberts WB, Han M. Clinical significance and treatment of biochemical recurrence after definitive therapy for localized prostate cancer. Sure Oncol 2009,18: 268-74.
  • 3Saad F, Hotte S, North S, Eigl B, Chi K, et al. Randomized phase Ⅱ trial of Custirsen (OGX-011) in combination with docetaxel or mitoxantrone as second-line therapy in patients with metastatic castrate-resistant prostate cancer progressing after first-line docetaxel: CUOG trial P-06c. Clin Cancer Research 2011,17: 5765-73.
  • 4Luo JH, Yu YP, Cieply K, Lin F, Deflavia P, etal. Gene expression analysis of prostate cancers. Mol Carcinog 2002,33: 25-35.
  • 5Yu YP, Song C, Tseng G, Ren BG, LaFramboise W, etal. Genome abnormalities precede prostate cancer and predict clinical relapse. Am J Patho12012,180: 2240-8.
  • 6Nelson WG, De Marzo AM, Yegnasubramanian S. Epigenetic alterations in human prostate cancers. Endocrinology 2009, 150:3991-4002.
  • 7Jeronimo C, Henrique R. Epigenetic biomarkers in urological tumors: a systematic review. Cancer Lett 2011.
  • 8Li B, Carey M, Workman JL. The role of chromatin during transcription. Cell 2007,128: 707-19.
  • 9Klose R J, Zhang Y. Regulation of histone methylation by demethylimination and demethylation. Nat Rev Mol Cell Bio 2007,8: 307-18.
  • 10Cedar H, Bergman Y. Linking DNA methylation and histone modification: patterns and paradigms. Nat Rev Genet 2009,10: 295-304.

共引文献34

同被引文献20

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部